Showing results (91-100 of 172) with videos related to
Sort By:
Pageof 18
Journal of Neurosurgery|January 21, 2017
Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgeryHideyuki Kano, Alejandro Morales-Restrepo, Aditya Iyer, et al.Plos One|January 11, 2021
CTLA-4 blockade and interferon-α induce proinflammatory transcriptional changes in the tumor immune landscape that correlate with pathologic response in melanomaArjun Khunger, Erin Piazza, Sarah Warren, et al.JAMA|November 5, 2014
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trialF Stephen Hodi, Sandra Lee, David F McDermott, et al.Plos One|July 21, 2015
Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma PatientsAhmad A Tarhini, Yan Lin, Haris Zahoor, et al.Journal of Surgical Oncology|April 12, 2011
Cutaneous melanoma: a model to study cancer metastasisStanley P L Leong, Jeffrey E Gershenwald, Seng-Jaw Soong, et al.Plos One|February 6, 2014
Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumabAhmad A Tarhini, Howard Edington, Lisa H Butterfield, et al.Cancers|May 13, 2023
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature ReviewIslam Eljilany, Arish Noor, Mahati Paravathaneni, et al.Cancer Immunology, Immunotherapy : CII|February 12, 2026
First-line ipilimumab plus nivolumab in advanced merkel cell carcinoma: a meta-analysis of prospective trials and real-world validation cohortTanya Ramadoss, Christian Palacios, Matthew Nichols, et al.Melanoma Research|August 22, 2017
A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanomaAhmad A Tarhini, Theofanis Floros, Hui-Min Lin, et al.Journal for Immunotherapy of Cancer|September 6, 2024
Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinomaTanya Ramadoss, Matthew Nichols, Christian Palacios, et al.Pageof 18